Security
PLx Pharma Inc. Common Stock · PLXP
PLXPNASDAQCommon stockHistorical · closed Apr 12, 2023CIK 1497504Updated Nov 16, 2026
Name history
PLx Pharma Inc. · through May 2, 2023Dipexium Pharmaceuticals, Inc. · through Apr 20, 2017Dipexium Pharmaceuticals, LLC · through Mar 13, 2014
PLXP price & chart
Historical security
This listing closed Apr 12, 2023. Live provider charts are shown only for current listings.
In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2021 · USDSource
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 76,642,000Source | 26,616,599Source | 18,502,746Source | 18,388,376Source |
| Property, Plant and Equipment, NetUSD | 858,000Source | 1,225,879Source | 1,466,646Source | 1,394,230Source |
| GoodwillUSD | 2,061,000Source | 2,061,022Source | 2,061,022Source | 2,061,022Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 69,392,000Source | 22,448,651Source | 14,001,304Source | 14,250,267Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 634,000Source | — | — | — |
| Inventory, NetUSD | 2,458,000Source | 100,000Source | 0Source | — |
| Assets, CurrentUSD | 73,476,000Source | 22,985,501Source | 14,283,255Source | 14,865,410Source |
| Prepaid Expense and Other Assets, CurrentUSD | 992,000Source | 393,470Source | 263,268Source | — |
| Operating Lease, Right-of-Use AssetUSD | 230,000Source | 327,161Source | 618,158Source | — |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 24,962,000Source | 16,163,564Source | 16,933,129Source | 11,944,083Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | 0Source | — | — | — |
| Common Stock, Value, IssuedUSD | 28,000Source | 13,912Source | 9,156Source | 8,744Source |
| Retained Earnings (Accumulated Deficit)USD | -148,274,000Source | -102,148,817Source | -86,938,163Source | -66,435,768Source |
| Stockholders' Equity Attributable to ParentUSD | 35,666,000Source | -10,931,855Source | -12,091,961Source | 6,444,293Source |
| Additional Paid in Capital, Common StockUSD | 183,912,000Source | 91,203,050Source | 74,837,046Source | 72,871,317Source |
| Liabilities and EquityUSD | 76,642,000Source | 26,616,599Source | 18,502,746Source | 18,388,376Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 11,879,000Source | 3,542,314Source | 6,093,430Source | 4,732,660Source |
| Other Liabilities, NoncurrentUSD | 136,000Source | 134,184Source | 409,431Source | 84,281Source |
| Additional Financial Items | ||||
| Long-term Debt, Current MaturitiesUSD | 0Source | 622,265Source | 3,658,121Source | 2,909,709Source |
| Long-term Debt, Excluding Current MaturitiesUSD | — | — | 622,265Source | 4,280,385Source |
cash flow · annual statements
| Line item | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 116,000Source | 124,617Source | 158,253Source | 200,957Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 2,884,000Source | 1,288,430Source | 875,851Source | 841,421Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | 635,000Source | -18,683Source | 449Source | -1,150Source |
| Increase (Decrease) in InventoriesUSD | 2,314,000Source | 143,380Source | — | 524,245Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -32,118,000Source | -12,243,592Source | -12,659,035Source | -9,499,231Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | 95,000Source | -102,000Source | -230,294Source | -654,870Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | 102,000Source | 241,736Source | 654,870Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 78,966,000Source | 20,792,939Source | 12,640,366Source | — |
| Repayments of Long-term DebtUSD | 625,000Source | 3,750,000Source | — | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | 46,943,000Source | 8,447,347Source | — | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | 22,400,000Source | — | — |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 6,000Source | 212,856Source | 600,303Source | 671,146Source |
| Income Taxes Paid, NetUSD | 0Source | — | — | — |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 2,900,000Source | 1,300,000Source | 875,851Source | 841,421Source |
| Amortization of Debt Issuance Costs and DiscountsUSD | 3,000Source | 91,879Source | 215,292Source | — |
| DepreciationUSD | 100,000Source | 124,617Source | 158,253Source | 200,957Source |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | -157,000Source | -218,150Source | -12,398Source | — |
| General and Administrative ExpenseUSD | — | 9,150,568Source | 10,026,627Source | 7,791,600Source |
| GoodwillUSD | 2,061,000Source | 2,061,022Source | 2,061,022Source | 2,061,022Source |
| Goodwill, Impairment LossUSD | — | 0Source | — | — |
| Income Tax Expense (Benefit)USD | 0Source | — | — | — |
| Inventory Write-downUSD | — | — | — | 770,619Source |
| Investment Income, InterestUSD | — | — | 405,239Source | 297,800Source |
| Net Income (Loss) Attributable to ParentUSD | -46,125,000Source | -15,210,654Source | -20,502,395Source | 896,480Source |
| Nonoperating Income (Expense)USD | -5,335,000Source | -1,751,542Source | -6,300,102Source | 11,857,637Source |
| Operating ExpensesUSD | 44,193,000Source | 13,489,542Source | 14,767,757Source | 11,714,265Source |
| Operating Lease, ExpenseUSD | 100,000Source | 400,000Source | — | — |
| Revenue from Contract with Customer, Including Assessed TaxUSD | 8,208,000Source | 30,430Source | 565,464Source | — |
income statement · annual statements
| Line item | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|
| Total RevenueUSD | — | — | — | 753,108Source |
| Cost of Goods and Services Sold | — | — | — | — |
| Selling, General and Administrative ExpenseUSD | 40,011,000Source | — | — | — |
| Operating Income (Loss)USD | -40,790,000Source | -13,459,112Source | -14,202,293Source | -10,961,157Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -46,125,000Source | -15,210,654Source | -20,502,395Source | 896,480Source |
| Income Tax Expense (Benefit)USD | 0Source | — | — | — |
| Net Income (Loss) Attributable to ParentUSD | -46,125,000Source | -15,210,654Source | -20,502,395Source | 896,480Source |
| Earnings Per Share, BasicUSD per share | — | -1.74Source | -3.84Source | 0.1Source |
| Earnings Per Share, DilutedUSD per share | — | 9,714,951Source | -3.84Source | 0.1Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 8,916,190Source | 8,733,220Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 8,916,190Source | 8,733,220Source |
| Additional Financial Items | ||||
| General and Administrative ExpenseUSD | — | 9,150,568Source | 10,026,627Source | 7,791,600Source |
| Goodwill, Impairment LossUSD | — | 0Source | — | — |
| Gross ProfitUSD | 3,403,000Source | — | — | — |
| Interest Expense, DebtUSD | — | 307,950Source | 994,979Source | 1,145,761Source |
| Interest Income (Expense), Nonoperating, NetUSD | 1,000Source | — | — | — |
| Investment Income, InterestUSD | — | — | 405,239Source | 297,800Source |
| Nonoperating Income (Expense)USD | -5,335,000Source | -1,751,542Source | -6,300,102Source | 11,857,637Source |
| Operating ExpensesUSD | 44,193,000Source | 13,489,542Source | 14,767,757Source | 11,714,265Source |
| Operating Lease, ExpenseUSD | 100,000Source | 400,000Source | — | — |
| Preferred Stock Dividends and Other AdjustmentsUSD | — | — | 13,750,806Source | — |
| Preferred Stock Dividends, Income Statement ImpactUSD | 2,525,000Source | 1,737,297Source | — | — |
| Research and Development ExpenseUSD | 4,182,000Source | 4,338,974Source | 4,741,130Source | 3,922,665Source |
| Revenue from Contract with Customer, Including Assessed TaxUSD | 8,208,000Source | 30,430Source | 565,464Source | — |